Differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green necessary to prevent post-hepatectomy liver failure associated with underlying diseases.
Carcinoma, Hepatocellular
/ epidemiology
Comorbidity
Diabetes Mellitus
/ epidemiology
Female
Hepatectomy
/ adverse effects
Humans
Indocyanine Green
/ metabolism
Liver
/ metabolism
Liver Cirrhosis
/ epidemiology
Liver Failure
/ prevention & control
Liver Neoplasms
/ epidemiology
Male
Margins of Excision
Metabolic Clearance Rate
Postoperative Complications
/ prevention & control
Retrospective Studies
Risk Factors
Safety
Functional hepatic reserve
Indocyanine green clearance rate
Posthepatectomy liver failure
Journal
Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
01
02
2021
accepted:
28
03
2021
pubmed:
31
5
2021
medline:
2
2
2022
entrez:
30
5
2021
Statut:
ppublish
Résumé
To evaluate differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green (RemK) necessary to prevent posthepatectomy liver failure (PHLF) associated with liver tumors and comorbidities. The subjects of this retrospective study were patients who underwent trisectionectomy, hemihepatectomy, or sectionectomy, other than left lateral sectionectomy, between 2011 and 2018, at the Shizuoka Cancer Center. We analyzed the risk factors for PHLF grades B and C and then evaluated the RemK in these groups, according to various risk factors. A total of 463 patients were selected for the analyses. Among the patients with PHLF grades B and C, those with diabetes mellitus (DM), liver cirrhosis (LC), or hepatocellular carcinoma (HCC) had significantly higher RemK than those without these diseases. Multivariate analysis identified RemK ≤ 0.078, DM, and creatinine clearance rate < 60 mL/min as independent risk factors for PHLF grades B and C. Hepatectomy for patients with DM, HCC, or LC requires more functional hepatic reserve than that evaluated by RemK.
Identifiants
pubmed: 34052906
doi: 10.1007/s00595-021-02310-9
pii: 10.1007/s00595-021-02310-9
doi:
Substances chimiques
Indocyanine Green
IX6J1063HV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
36-45Informations de copyright
© 2021. Springer Nature Singapore Pte Ltd.
Références
Ohwada S, Kawate S, Hamada K, Yamada T, Sunose Y, Tsutsumi H, et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg. 2006;93(3):339–46. https://doi.org/10.1002/bjs.5258 .
doi: 10.1002/bjs.5258
pubmed: 16498606
Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243(3):364–72. https://doi.org/10.1097/01.sla.0000201482.11876.14 .
doi: 10.1097/01.sla.0000201482.11876.14
pubmed: 16495702
pmcid: 1448943
Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57. https://doi.org/10.1097/SLA.0b013e31815f6e5b .
doi: 10.1097/SLA.0b013e31815f6e5b
pubmed: 18156923
Kawamura T, Noji T, Okamura K, Tanaka K, Nakanishi Y, Asano T, et al. Postoperative liver failure criteria for predicting mortality after major hepatectomy with extrahepatic bile duct resection. Dig Surg. 2018. https://doi.org/10.1159/000486906 .
doi: 10.1159/000486906
pubmed: 29421802
Lee EC, Park SJ, Han SS, Shim JR, Park HM, Lee SD, et al. Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33(4):958–65. https://doi.org/10.1111/jgh.13966 .
doi: 10.1111/jgh.13966
pubmed: 28843035
Olthof PB, Wiggers JK, Groot Koerkamp B, Coelen RJ, Allen PJ, Besselink MG, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg. 2017;225(3):387–94. https://doi.org/10.1016/j.jamcollsurg.2017.06.007 .
doi: 10.1016/j.jamcollsurg.2017.06.007
pubmed: 28687509
Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular cartinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterol. 1999;111(4):1018–22. https://doi.org/10.1016/s0016-5085(96)70070-7 .
doi: 10.1016/s0016-5085(96)70070-7
Makuuchi M, Kosuge T, Takayama T, Yamazaki Y, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9(4):298–304. https://doi.org/10.1002/ssu.2980090404 .
doi: 10.1002/ssu.2980090404
pubmed: 8210909
Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97(8):1260–8. https://doi.org/10.1002/bjs.7084 .
doi: 10.1002/bjs.7084
pubmed: 20602507
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. https://doi.org/10.1159/000180580 .
doi: 10.1159/000180580
pubmed: 1244564
Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Aramaki T, et al. The pitfalls of left trisectionectomy or central bisectionectomy for biliary cancer: anatomical classification based on the ventral branches of segment vi portal vein relative to the right hepatic vein. J Gastrointest Surg. 2017;21(9):1453–62. https://doi.org/10.1007/s11605-017-3486-y .
doi: 10.1007/s11605-017-3486-y
pubmed: 28667434
Watanabe N, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, et al. A predictive scoring system for insufficient liver hypertrophy after preoperative portal vein embolization. Surgery. 2018;163(5):1014–9. https://doi.org/10.1016/j.surg.2017.11.026 .
doi: 10.1016/j.surg.2017.11.026
pubmed: 29501348
Pringle JHV. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48(4):541–9. https://doi.org/10.1097/00000658-190810000-00005 .
doi: 10.1097/00000658-190810000-00005
pubmed: 17862242
pmcid: 1406963
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24. https://doi.org/10.1016/j.surg.2010.10.001 .
doi: 10.1016/j.surg.2010.10.001
pubmed: 21236455
Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer 4
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. https://doi.org/10.1038/bmt.2012.244 .
doi: 10.1038/bmt.2012.244
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53. https://doi.org/10.2337/diacare.27.5.1047 .
doi: 10.2337/diacare.27.5.1047
pubmed: 15111519
Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, Buchler MW, et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol. 2011;18(13):3640–9. https://doi.org/10.1245/s10434-011-1829-6 .
doi: 10.1245/s10434-011-1829-6
pubmed: 21674269
Li Q, Wang Y, Ma T, Lv Y, Wu R. Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: a systematic review and meta-analysis. PLoS ONE. 2017;12(2):e0171129. https://doi.org/10.1371/journal.pone.0171129 .
doi: 10.1371/journal.pone.0171129
pubmed: 28182632
pmcid: 5300262
Garcia-Compean D, Gonzalez-Gonzalez JA, Lavalle-Gonzalez FJ, Gonzalez-Moreno EI, Maldonado-Garza HJ, Villarreal-Perez JZ. The treatment of diabetes mellitus of patients with chronic liver disease. Ann Hepatol. 2015;14(6):780–8. https://doi.org/10.5604/16652681.1171746 .
doi: 10.5604/16652681.1171746
pubmed: 26436350
El-serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460–8. https://doi.org/10.1053/j.gastro.2003.10.065 .
doi: 10.1053/j.gastro.2003.10.065
pubmed: 14762783
Miller JD, Richman DC. Preoperative evaluation of patients with diabetes mellitus. Anesthesiol Clin. 2016;34(1):155–69. https://doi.org/10.1016/j.anclin.2015.10.008 .
doi: 10.1016/j.anclin.2015.10.008
pubmed: 26927745
Tsai MS, Lin CL, Chang SN, Lee PH, Kao CH. Diabetes mellitus and increased postoperative risk of acute renal failure after hepatectomy for hepatocellular carcinoma: a nationwide population-based study. Ann Surg Oncol. 2014;21(12):3810–6. https://doi.org/10.1245/s10434-014-3777-4 .
doi: 10.1245/s10434-014-3777-4
pubmed: 24841349
Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, et al. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: a 30-year, single-center experience. Anticancer Res. 2013;33(11):5097–105.
pubmed: 24222155
Kamarajah SK. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): a surveillance, end results and epidemiology (SEER) database analysis. Asian J Surg. 2018;41(6):551–61. https://doi.org/10.1016/j.asjsur.2018.01.001 .
doi: 10.1016/j.asjsur.2018.01.001
pubmed: 29454570
Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229(2):210–5. https://doi.org/10.1097/00000658-199902000-00008 .
doi: 10.1097/00000658-199902000-00008
pubmed: 10024102
pmcid: 1191633
Dong J, Zhang XF, Zhu Y, Ma F, Liu C, Wang WL, et al. The value of the combination of fibrosis index based on the four factors and future liver remnant volume ratios as a predictor on posthepatectomy outcomes. J Gastrointest Surg. 2015;19(4):682–91. https://doi.org/10.1007/s11605-014-2727-6 .
doi: 10.1007/s11605-014-2727-6
pubmed: 25583440
Gu J, Zhang E, Liang B, Zhang Z, Chen X, Huang Z. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function. World J Surg Oncol. 2020;18(1):79. https://doi.org/10.1186/s12957-020-01854-3 .
doi: 10.1186/s12957-020-01854-3
pubmed: 32326968
pmcid: 7181509
Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32–41. https://doi.org/10.1016/j.ejso.2016.05.026 .
doi: 10.1016/j.ejso.2016.05.026
pubmed: 27283892
Kubo S, Shiomi S, Tanaka H, Shuto T, Takemura S, Mikami S, et al. Evaluation of the effect of portal vein embolization on liver function by 99mTc-galactosyl human serum albumin scintigraphy. J Surg Res. 2002;107(1):113–8. https://doi.org/10.1006/jsre.2002.6503 .
doi: 10.1006/jsre.2002.6503
pubmed: 12384072
Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol. 2011;46(7):938–43. https://doi.org/10.1007/s00535-011-0406-x .
doi: 10.1007/s00535-011-0406-x
pubmed: 21523415